# Safety and Immunogenicity Study of AERAS-456 Vaccine for Tuberculosis

> **NCT01967134** · PHASE1 · COMPLETED · sponsor: **Aeras** · enrollment: 25 (actual)

## Conditions studied

- Latent Tuberculosis
- Latent Tuberculosis Bacteriology and Histology Unknown

## Interventions

- **BIOLOGICAL:** H56:IC31

## Key facts

- **NCT ID:** NCT01967134
- **Lead sponsor:** Aeras
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-12
- **Final completion:** 2013-06
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2019-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01967134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01967134, "Safety and Immunogenicity Study of AERAS-456 Vaccine for Tuberculosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01967134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*